Navneet Majhail, MD of Cleveland Clinic, gives an overview of Abstract 69: Genetic Alterations Predict Outcomes in Patients with Myelodysplastic Syndrome Receiving Allogeneic Hematopoietic Stem Cell Transplantation, which was presented at the 58th ASH Annual Meeting in San Diego, CA.